Fundraising Choices in Life Sciences: What, When & Why?
By Linda Rubinstein
This article is the second in a two-part series about fundraising strategies for life science companies. In our last article, A Menu of Financing Alternatives for Life Science Companies, we looked at the continuum of choices available to life science companies who are actively engaged in fundraising to power up…Read More
Read MoreUpcoming Webinar 8-15: SaaS Company Benchmarking: The Why & How
By FLG Partners
Join FLG partner, Eric Mersch for the launch of a new webinar series SaaS Conversations hosted by OPEXEngine. Session #1: “Benchmarking Your Company: The Why and How” will be held via Zoom on August 15th at 11AM PST. Benchmarking is a proven method to improve operational efficiency and growth. By…Read More
Read MoreA Menu of Financing Alternatives for Life Science Companies
By Linda Rubinstein
This article is the first in a two-part series about fundraising strategies for life science companies. A Menu of Financing Alternatives for Life Science Companies Fundraising Choices in Life Sciences: What, When & Why? Life science companies, from emerging to evolved, therapeutics to diagnostics, solo or partnered, are constantly fundraising….Read More
Read MoreProfitability at Professional Service Firms: Do You “Get it,” or Not?
By Jonathan Wolter
As a professional, one might presume that the economics of consulting firms, marketing and PR agencies, law and accounting firms, and other types of professional service organizations are relatively straightforward. In terms of making money and turning a profit, many people think – “how hard can it be, right?” Yet,…Read More
Read More